Danuglipron
id:
danuglipron-213-1102196
title:
Danuglipron
text:
Danuglipron is a small-molecule GLP-1 agonist developed by Pfizer that, in an oral formulation, is under investigation as a therapy for diabetes mellitus. Initial results from a randomized controlled trial indicate that it reduced weight and improved diabetic control. The most commonly reported adverse events were nausea, diarrhea, and vomiting.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Danuglipron
date created:
2023-05-23T20:18:32Z
date modified:
2024-09-12T09:12:14Z
main entity:
{"identifier":"Q63141738","url":"https://www.wikidata.org/entity/Q63141738"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a5/Danuglipron.svg","width":495,"height":185}
fields total:
13
integrity:
16